Hello, everyone, and how are you this fine, sunny morning? The middle of the week has arrived, as you may know, so why not celebrate with a delicious cup of stimulation? We are enjoying almond toffee, for those who like to live vicariously, and invite you to join us. And why not? The neurons can always use a little help, so why deny them? Speaking of assistance, here are some tidbits to get you started. Hope your day is productive and rewarding, and of course, do keep in touch …

The Trump administration announced it would name Ned Sharpless, the director of the National Cancer Institute, as the acting commissioner of the Food and Drug Administration next month, STAT says. The announcement came just a week after the current commissioner, Scott Gottlieb, announced he plans to resign in early April. Sharpless, a physician and scientist, ran the Lineberger Comprehensive Cancer Center at the University of North Carolina before taking over at the NCI in October 2017.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy